Hypertension Flashcards
normal BP followup time
1 year
elevated BP followup time and tx
3-6 months, non pharm
stage 1 tx and followup
ASC >10% or comorbid = nonpharm + 1 agent - 1 month
ASCVD <10% = nonpharm - 3-6 months
stage 2 tx and followup
nonpharm and 2+ agents - 1 month
HTN pts at goal followup time?
3-6 months
tx initiation BP for ASCVD >10% or CVD
130/80
tx initiation for diabetes
130/80
tx initiation for secondary stroke
140/90
SPRINT trial pts and outcome
no diabtetes/stroke
tighter BP goal decreased CV events 25%
ACCORD trial pts and outcome
diabetes and CVD
no death benefit with tighter goal
decrease stroke risk 41%
stable ischemic heart disease agents
ACE/ARB or beta blocker
if angina: dihydropyridine CCB
heart failure reduced ejection fraction agent
avoid non-DHP CCBS
heart failure preserved ejection fraction agent
ACE/ARB, diuretic, beta blocker
CKD agent
ACE/ARB if albuminuria >300
renal transplant agent
DHP CCB
secondary stroke prevention agent
ACE/ARB and/or thiazide only if BP >140/90
diabetes agents
any first line
ACE/ARB if proteinuria
atrial fib agents
ARB
black patients without CKD or HF agents
thiazide or CCB
pregnancy agents
methyldopa
nifedipine
labetalol
thiazide diuretics drugs
HCTZ, chlorthalidone, indapamide, metalozone
thiazides are more effective for pts with a CrCl > what
> 30 mL/min
hydrochlorothiazide max dose and dosing
25 mg daily
chlorthalidone max dose and dosing
100 mg daily
thiazide diuretics effect on potassium
hypokalemia
thiazide diuretics adverse effects
hypokalemia, hypomagnesemia, hypercalcemia, hyperuricemia, hyperglycemia, sexual dysfunction, increase in triglycerides/cholesterol
thiazide diuretics contraindications
sulfa allergy, anuria
loop diuretics drugs
furosemide, torsemide, bumetanide, ethacrynic acid
loop diuretics more effective with CrCl < what
30
furosemide max dose and dosing
80 mg once or twice daily
loop diuretics effect on potassium
hypokalemia
loop diuretics adverse effects
hypokalemia, hypomagnesmia, hypoclacemia, hyperuricemia, ototoxicity
loop diuretics contraindications
sulfa allergy
aldosterone antagonists drugs
spironolactone, eplerenone
ALLHAT trial
thiazide should be first line
PATHWAY 2 trial
spironolactone with resistant HTN
do not initiate spironolactone with what potassium level?
greater than 5
spironolactone max dose and dosing
100 mg and daily/BID
consider holding dose if potassium ____
> 5.5
spironolactone adverse effects
hyperkalemia, hyponatremia, gynecomastia
contraindications to aldosterone antagonists
use with potassium-sparing diuretics
potassium sparing diuretics drugs
triamterene, amiloride
potassium sparing diuretics use
concominant with thiazides
potassium sparing diuretics caution
GOUT, if uncontrolled its bad cause hyperuricemia
ACE inhibitors side effects
cough, angioedema, hyperkalemia, acute renal failure
ACE inhibitors contraindications
angioedema on ACE
concominant use of alirisken
pregnancy/breastfeeding
ARB adverse effects
angioedema, hyperkalemia, acute renal failure
ARB contraindications
angioedema on ARB
concominant use with alirisken
pregnancy/breastfeeding
consider holding ACE/ARB if potassium ____
greater than 5.5
alirisken
no cough
dont use with ACE/ARB
alirisken adverse effects
hyperkalemia, diarrhea, dizziness, orthostatic hypotension
dihydropyridine calcium channel blockers
amlodipine, nifedipine
DHP uses
Reynauds syndrome, elderly with isolated systolic
amlodipine max dose
10 mg
nifedipine max dose
120 mg
lisinopril max dose
40 mg
DHP adverse effects
reflex tachycardia, peripheral edema
DHP interactions
grapefruit, CYP3A4
non DHP uses
afib, angina who cant do beta blocker
non DHP does what to heart rate
decreases
non DHP drugs
diltiazem and verapamil
non DHP adverse effects
bradycardia, AV block, constipation (verapamil esp)
non DHP drug interactions
concominant use of beta blockers
grapefruit juice
CYP 3A4
labs required for CCB monitoring
none
peripheral edema is ___
dose dependent
what release is preferred in CCBs
extended release
CCB drug for heart failure
amlodipine
beta blockers use
HF or CAD
avoid abrupt cessation of what drugs?
beta blockers and alpha 2 agonists
metoprolol tartrate max dose and frequency
450 mg BID
metoprolol succinate max dose and frequency
400 mg daily
cardioselective beta blockers
metoprolol, atenolol, bisoprolol, bextaxolol, nebivolol
non selective beta blockers
propranolol
avoid which drugs in asthma / COPD?
non selective beta blockers (propranolol)
ISA beta blockers
acebutolol, penbutolol, pindolol
avoid what drugs in heart failure
ISA beta blockers
mixed alpha/beta beta blockers
carvedilol, labetalol
carvedilol max dose and frequency
50 mg BID
beta blockers adverse effects
masked hypoglycemia, bradycardia, exercise intolerance, depression, fatigue
beta blocker contrainidcations
heart block, decompensated HF, post-MI, severe bradycardia
direct arterial vasodilators
minoxidil and hydralazine
minoxidil and hydralazine special conditions use
severe CKD / hemodialysis
minoxidil and hydralazine must have concominant therapy with what
beta blocker and diuretic
frequncy of hydralazine
2-4 times daily
frequency of minoxidil
1-3 times daily
hydralazine/minoxidil side effects
tachycardia, chest pain
lupus like sydrome/rash with hydralazine
hair growth with minoxidil
minoxidil boxed warning
pericarditis, pericardial effusion
alpha 1 blockers drugs
prazosin, doxazosin, terazosin
alpha blockers use
HTN with BPH
central alpha 2 agonist drugs
clonidine, methyldopa, guanfacine
alpha 2 agonist side effects
CNS depression, dizzy, reflex tachycardia
must wean off of which med?
clonidine, wean off beta blocker first then 3-4 days to quit clonidine
monitoring paramaters for ACE/ARB
BUN/Scr, potassium
monitoring parameters for CCBs
heart rate
monitoring parameters for aldosterone antagonists
BUN/SCr, potassium
monitoring parameters for other diuretics
BUN/Scr, electrolytes, uric acid
beta blockers monitoring parameters
HR
steps of resistant HTN
- 3 drug regimen (ace/arb, ccb, diuretic) max dose
- chlorthalidone
- spironolactone
- beta blocker if HR >70, clonidine if <70
- hydralazine
- minoxidil